Related Experiment Video
Updated: Mar 7, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.6K
Intermittent Therapy with Corticotrophin in Vitiligo
Indian Journal of Dermatology, Venereology and Leprology
|February 23, 2017
Summary
Adrenocorticotropic hormone (ACTH) therapy shows promise for treating vitiligo, potentially reducing treatment duration. This study explored ACTH
Area of Science:
- Dermatology
- Immunology
- Endocrinology
Background:
- Melanin formation and behavior are influenced by fundamental factors.
- Vitiligo etiology is hypothesized to involve autoimmune, neurogenic, or melanocyte self-destruction mechanisms.
- Steroids, effective in autoimmune diseases, possess anti-inflammatory properties.
Purpose of the Study:
- To investigate the efficacy of Adrenocorticotropic hormone (ACTH) therapy in vitiligo cases.
- To evaluate the effectiveness and potential adverse reactions of ACTH treatment for vitiligo.
- To explore the potential role of autoimmune factors in vitiligo management.
Main Methods:
- ACTH therapy was administered to 27 vitiligo patients.
- Effectiveness of the treatment was assessed.
- Untoward reactions were documented and analyzed.
Main Results:
- ACTH therapy demonstrated effectiveness in treating vitiligo.
- The duration of therapy required was significantly reduced.
- Case reports were discussed to illustrate treatment outcomes.
Conclusions:
- ACTH therapy is an effective treatment for vitiligo.
- This therapeutic approach can lead to a considerable reduction in treatment duration.
- Further investigation into ACTH's role in vitiligo, particularly in autoimmune-related cases, is warranted.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
584
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
584
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
618
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
618
01:29Inflammatory Bowel Disease IV: Pharmacological Management
874
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
874
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
319
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
319
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
987
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
987
01:29Drugs for Treatment of Ulcerative Colitis in IBD
578
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
578